FOLD FY 2014 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+237.2% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$69M-5612.8% margin

Net Income

-$69M-5631.2% margin

EPS (Diluted)

$-0.93

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$210M

Total Liabilities

$88M

Stockholders' Equity

$122M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$363,000	+237.2%
Gross Profit	$1M	-$13M	+109.3%
Operating Income	-$69M	-$64M	-7.0%
Net Income	-$69M	-$60M	-15.6%